The largest database of trusted experimental protocols

6 protocols using silac rpmi 1640

1

Culturing CD19-CAR T Cells and Raji B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD19-CAR T cells and Raji B cells were initially cultured in RPMI 1640 supplemented with 10% (v/v) FBS, 2mM L-glutamine, 100μ/mL penicillin, and 100 μg/mL Streptomycin and maintained under standard conditions (5% CO2, 37 °C). After 12 days in culture, Raji B cells were collected and washed twice with SILAC RPMI 1640 (Thermo Fisher Scientific, Waltham, MA) before reconstitution in SILAC RPMI 1640 medium (Thermo Fisher Scientific, Waltham, MA) containing 0.38 mM 13C6, 15N4 Arginine, 0.22 mM 13C6, 15N2 Lysine (Cambridge Isotope Laboratories, Andover, MA), 10% dialyzed FBS (Gibco Life Technologies, Guilford, CT), 2 mM L-glutamine, 100 U/mL Penicillin, and 100 μg/mL Streptomycin (Cytiva, Malborough, MA) and maintained for a total of 8 doublings under standard conditions (5% CO2, 37 °C). During this time, CD19-CAR T cells were expanded and maintained in RPMI 1640 medium supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 U/mL Penicillin, and 100 μg/mL Streptomycin.
+ Open protocol
+ Expand
2

Bone Marrow Dendritic Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDC-RPMI: 10% fetal bovine serum (FBS, HyClone), 1% L-glutamine (Gibco), 1% Penicillin/Streptomycin (P/S, Gibco), 55μM 2-ME (Sigma), and 10μg/mL mouse GM-CSF (R&D Systems) in RPMI-1640 (Corning). Complete (C)-DMEM: 10% bovine calf serum (BCS, HyClone,) and 1% P/S in standard DMEM (Corning). L-ARG-free SILAC RPMI: 10% dialyzed FBS (Corning), 1% P/S, 219μM L-lysine-HCl (Sigma), and 55μM 2-ME in SILAC RPMI-1640 (Thermo Scientific).
+ Open protocol
+ Expand
3

CD44v9 Regulation of EMT in ESCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human ESCC cell lines (TE1, 3, 5, 6, 8, 11, 12, 13) were cultured in SILAC RPMI‐1640 (Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% fetal bovine serum (FBS) (Biological Industries, Cromwell, CT, USA), at 37°C in an atmosphere containing 5% CO2.
A CD44v9‐specific siRNA28 was synthesized by Thermo Fisher Scientific. Among cell lines tested the expression of CD44v9 was highest in TE6 cells, which were therefore selected for further study. TE6 cells were seeded in a 6‐well plate (0.25 × 106 cells per well) and reverse transfected with 30 nmol of CD44v9 siRNA in the presence of Lipofectamine RNAimax reagent (Thermo Fisher Scientific) for 72 hour, according to the procedure provided by the manufacturer. A duplex Stealth RNAi (siCONT) was used as a nontargeting siRNA.
To induce EMT, TE6 cells were seeded in a 6‐well plate (0.25 × 106 cells per well) and treated with TGF‐β1 (final concentration of 20 ng/mL) (Invitrogen, Carlsbad, CA, USA) for 72 hour.
+ Open protocol
+ Expand
4

Activation and Culture of Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured in RPMI-1640 medium supplemented with 2 mM glutamine, 1% (v/v) non-essential amino acids, 1% (v/v) sodium pyruvate, penicillin (50 U ml−1), streptomycin (50 μg ml−1; all from Invitrogen), and 5% (v/v) human serum (Swiss Blood Center, Basel). Human T cells were activated with plate-bound anti-CD3 (5 μg/ml, clone TR66) and anti-CD28 (1 μg/ml, clone CD28.2, BD Biosciences) for 48 h in 96-well Nunc Maxisorb plates. 1.5×105 T cells were plated per well. After 48 h of activation, cells were transferred to 96-well U-bottom plates and cultured in IL-2 containing media (500 U/ml). In experiments, in which T cells that were cultured without a stimulus, 1.5×105 T cells were plated in 96-well U-bottom plates and 200 μ1 of culture medium was added per well. Drugs were added at the following concentrations: CHX (50 μg/ml) and bortezomib/PS341 (10 μM).
For SILAC experiments, SILAC RPMI-1640 (GIBCO) was supplemented with 73 mg/l Lys-8 HCl and 42 mg/l Arg-10 HCl, 2 mM glutamine, 1% (v/v) sodium pyruvate, penicillin (50 U/ml), streptomycin (50 μg/ml; all from Invitrogen), and 5% (v/v) dialyzed human serum.
+ Open protocol
+ Expand
5

Luminol-Based Monocyte Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocytes were resuspended in phenol red free SILAC RPMI 1640 (Gibco, Thermo Fisher) supplemented with 2 mM GlutaMAX (Gibco, Thermo Fisher), 5 mM HEPES (Sigma-Aldrich), 0.133 mM l-arginine (Sigma-Aldrich), 0.27 mM l-lysine (Sigma-Aldrich), and 2.5% FCS in a density of 3 × 105/200 µl and seeded in a white 96-well plate (Nunc, Thermo Fisher). After 2 h of incubation at 37°C and 5% CO2, luminol reagent (140 µM; Cayman Chemicals) was added, and cells were stimulated with 100 ng/ml LPS. Luminescence from oxidized luminol was measured with a platereader (FluoStar Optima, BMG Labtech) over 180 min. Activation of the AMPK with 1 mM AICAR (Sigma-Aldrich) was done prior to LPS stimulation.
+ Open protocol
+ Expand
6

Activation and Culture of Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured in RPMI-1640 medium supplemented with 2 mM glutamine, 1% (v/v) non-essential amino acids, 1% (v/v) sodium pyruvate, penicillin (50 U ml−1), streptomycin (50 μg ml−1; all from Invitrogen), and 5% (v/v) human serum (Swiss Blood Center, Basel). Human T cells were activated with plate-bound anti-CD3 (5 μg/ml, clone TR66) and anti-CD28 (1 μg/ml, clone CD28.2, BD Biosciences) for 48 h in 96-well Nunc Maxisorb plates. 1.5×105 T cells were plated per well. After 48 h of activation, cells were transferred to 96-well U-bottom plates and cultured in IL-2 containing media (500 U/ml). In experiments, in which T cells that were cultured without a stimulus, 1.5×105 T cells were plated in 96-well U-bottom plates and 200 μ1 of culture medium was added per well. Drugs were added at the following concentrations: CHX (50 μg/ml) and bortezomib/PS341 (10 μM).
For SILAC experiments, SILAC RPMI-1640 (GIBCO) was supplemented with 73 mg/l Lys-8 HCl and 42 mg/l Arg-10 HCl, 2 mM glutamine, 1% (v/v) sodium pyruvate, penicillin (50 U/ml), streptomycin (50 μg/ml; all from Invitrogen), and 5% (v/v) dialyzed human serum.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!